Whether the hospital can be reimbursed for purchasing Osimertinib (Tagrisso) and the process description

Osimertinib is a third-generation EGFR tyrosine kinase inhibitor mainly used to treat EGFR mutation-positive non-small cell lung cancer. In China, osimertinib has been launched and included in medical insurance. The common specifications are 80mg*30 tablets, and the latest price is about 5,000 to 6,000 yuan. Being included in medical insurance means that eligible patients can reduce their financial burden through medical insurance reimbursement when purchasing drugs in the hospital, but the specific reimbursement ratio and out-of-pocket amount need to be determined according to local medical insurance policies.

When hospitals purchase and reimburse osimertinib, patients generally need to provide prescriptions and medical records issued by doctors, including EGFR gene testing reports and records related to lung cancer diagnosis and treatment. After the pharmacy is approved, the medical insurance system will settle the fees in accordance with local regulations. When purchasing medicines, patients should understand the medical insurance processing procedures of their hospital in advance so as to successfully complete the reimbursement procedures and avoid delays in medication due to incomplete information.

For patients who cannot obtain osimertinib domestically, generic drug options also exist in overseas markets. For example, the generic drugs on the market in Laos and Bangladesh have a specification of 80mg*30 tablets. The price per box is only a few hundred yuan, and the drug ingredients are basically the same as the original drugs. Overseas generic drugs can be an economically viable alternative, but they must be purchased through legal channels and used under the guidance of doctors to ensure efficacy and safety.

Generally speaking, osimertinib purchased in domestic hospitals can be reimbursed through medical insurance, reducing the financial pressure on patients, but it is necessary to follow the hospital's reimbursement process and provide complete information. Although overseas generic drugs are cheap, attention should be paid to the formality of the channels and medication guidance. During use, patients should follow up and monitor their blood and liver and kidney functions regularly to ensure the safety and therapeutic effect of the drug.

Reference materials:https://www.drugs.com/